发明名称 |
LIVER/PLASMA CONCENTRATION RATIO FOR DOSING HEPATITIS C VIRUS PROTEASE INHIBITOR |
摘要 |
Compositions and therapeutic combinations are provided including at least one compound selected from the group consisting of compounds of Formulae I to XXVI as defined herein as well as methods of treatment, prevention or amelioration of one or more symptoms of hepatitis C, treating disorders associated with HCV virus, modulating activity of HCV protease, in which liver to plasma concentration ratio of the compound ranges from about 2:1 to about 10:1. |
申请公布号 |
WO2006130687(A3) |
申请公布日期 |
2007.09.20 |
申请号 |
WO2006US21116 |
申请日期 |
2006.05.31 |
申请人 |
SCHERING CORPORATION;WHITE, RONALD, E.;CHENG, KUO-CHI |
发明人 |
WHITE, RONALD, E.;CHENG, KUO-CHI |
分类号 |
A61K38/04;A61P21/00 |
主分类号 |
A61K38/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|